Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the efficacy of confocal laser endomicroscopy in assessment of colonic permeability against conventional sugar absorption test.
Increased intestinal permeability has been shown significant in many gastrointestinal diseases, including inflammatory bowel disease and recently irritable bowel syndrome. The conventional test methods of permeability is sugar absorption test which is neither reliable and practical. Confocal laser endomicrosopy is a newly developed device which allows in vivo and real time observation of gastrointestinal mucosa. In our preliminary study we found that the commonly used contrast agent, fluorescein sodium shew differences of leakage into colonic crypt lumen among different patients. The fluorescein leakage might be due to abnormal colonic permeability, so we planed to compare the fluorescein leakage under confocal laser endomicroscopy with conventional sucralose absorption test.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Inflammation | Patients with long standing history or short onset of ulcerative colitis. | ||
| Healthy controls | Asymptomatic individuals admitted for health surveillance or patients for follow up after polypectomy. | ||
| Irritable bowel syndrome | Patients admitted to outpatient department with symptoms meeting ROME III criteria of irritable bowel syndrome. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Fluorescein leakage under confocal laser endomicroscopy observation of colonic mucosa. | Within the 30 minutes after injection of fluorescein |
| Measure | Description | Time Frame |
|---|---|---|
| Total sucralose excretion. | Within the 24 hours after drinking of sucralose |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Known cancers or abdominal surgery
Scheduled for endoscopic treatment
Alarm symptoms such as anaemia, gastrointestinal bleeding or obstruction, marked weight loss, abdominal mass
Under conditions such as:
Inability to provide informed consent
Known allergy to fluorescein sodium
Not provided
Not provided
Patients with indications for colonoscopy in Qilu Hospital outpatient and inpatient department are the study population of this study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yanqing Li, PhD. MD. | Contact | 86-531-8216923 | 82169508 | qiluliyanqign@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Yanqing Li, PhD. MD. | Department of Gastroenterology, Qilu Hospital, Shandong University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Gastroenterology, Qilu Hospital, Shandong University | Recruiting | Jinan | Shandong | 250012 | China |
Not provided
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D003093 | Colitis, Ulcerative |
| D043183 | Irritable Bowel Syndrome |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Biopsies during colonoscopy.
| D003092 | Colitis |
| D003108 | Colonic Diseases |
| D003109 | Colonic Diseases, Functional |